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Abstract
Epigenetic research leads to complex data structures. Since parametric model assumptions
for the distribution of epigenetic data are hard to verify we introduce in the present work a
nonparametric statistical framework for two-group comparisons. Furthermore, epigenetic
analyses are often performed at various genetic loci simultaneously. Hence, in order to be
able to draw valid conclusions for specific loci, an appropriate multiple testing correction is
necessary. Finally, with technologies available for the simultaneous assessment of many in-
terrelated biological parameters (such as gene arrays), statistical approaches also need to
deal with a possibly unknown dependency structure in the data. Our statistical approach to
the nonparametric comparison of two samples with independent multivariate observables is
based on recently developed multivariate multiple permutation tests. We adapt their theory
in order to cope with families of hypotheses regarding relative effects. Our results indicate
that the multivariate multiple permutation test keeps the pre-assigned type I error level for
the global null hypothesis. In combination with the closure principle, the family-wise error
rate for the simultaneous test of the corresponding locus/parameter-specific null hypothe-
ses can be controlled. In applications we demonstrate that group differences in epigenetic
data can be detected reliably with our methodology.
Introduction
Epigenetic mechanisms, such as deoxyribonucleic acid (DNA) methylation, constitute a central
principle of gene regulation. In contrast to other forms of regulation, e. g., transcriptional or
translational control, DNA methylation occurs without changing the primary DNA sequence,
see [1]. It refers to the selective addition of a methyl group to the 50-carbon of the cytosine base
and occurs exclusively in the dinucleotide cytosine phosphate guanine (CpG). DNAmethyla-
tion occurs non-randomly and, if the target CpGs are located in the proximity of coding re-
gions, is often associated with inactive gene expression. Oppositely, demethylation of CpG in
regulatory elements is commonly accompanied by activation of expression. Shifts in DNA
methylation have been observed in cells for various diseases. These changes reflect the loss of
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tight gene regulation as often observed in cancer. Aberrant methylation is a hallmark of dysre-
gulation of gene control, see [2].
On the other hand, substantial variations in methylation signals in tissues or body fluids
may—while still disease associated—be derived from different changes. They may result from
the changing abundance of specialized cells. For example, bacterial infections cause an innate
immune response to infection, and consequently the number of neutrophils is abruptly escalat-
ed. This is invariably accompanied by an equivalent increase of neutrophil-specific methylation
marks. Similarly, during human immunodeficiency virus infection, a drop of CD4+ T-cells is
observed and along with that the CD4 T-cell specific DNAmethylation signals drop when
measuring patient whole blood or leukocytes. Thus, and insofar as methylation controlled
genes are cell-type specific, the concept of differential DNA methylation is employed for the
discrimination and quantification of cell types, as initially shown in [3] and used in [4].
In this work, we are concerned with statistical methods in order to identify differentially
methylated loci, which may be disease markers, between two groups (typically: diseased versus
non-diseased). Irrespective of the exact application, numerous different technologies are em-
ployed to identify specific methylation markers, see [5]. As consequence, studies remain dispa-
rate with limited comparability between different experiments. This also extends to statistical
analysis, although for this aspect a more unified approach appears feasible, since for the majori-
ty of the approaches an estimate of the methylation proportion (β-value) at each CpG locus for
each observational unit is reported. Most current studies involve the analysis of the methyla-
tion status of multiple loci separately (e. g., Illumina methylation arrays) or on a fixed se-
quence/pattern of loci (e. g., Methylight). Statistically, this leads to a multiple test problem. It
requires a multiple statistical hypothesis test in order to find significant differences between the
groups in terms of the β-value at each locus or the methylation status of a sequence of loci, re-
spectively. Depending on the objective of the study different types of multiplicity correction are
appropriate. In confirmatory studies one typically aims at strong control of the family-wise
error rate (FWER), meaning that the probability for at least one type I error among the locus-
specific tests is bounded by a pre-defined significance level α. In this context, a particular chal-
lenge for statistical methodology is constituted by pronounced dependencies among the β-val-
ues between the loci.
Such dependencies result from at least two different principles: On one hand, due to linkage
disequilibrium (see [6]), physical proximity of different CpG sites may cause bivariate depen-
dency, with an increasing distance between two loci generally resulting in lower bivariate de-
pendency, cf. [7]. With respect to this, however, functionally relevant gene regulation may
limit the linkage (both in extent and distance). In the Foxp3 gene, for example, the promotor
region is demethylated in all T-cell types whereas the regulatory T-cell (Treg) specific demeth-
ylated region is fully methylated in most and fully demethylated in just one cell type; cf. [8]. On
the other hand, when considering cell type specific markers, there is also a functional-biological
dependency, which must be taken into account. For example, the number of overall T-cells in
peripheral blood also influences (or depends on) the number of all cells and the number of, e.
g., regulatory T-cells. Hence, the number of demethylated CD3-intergenic regions—present
only on all T-cells—somewhat correlates with the number of demethylated glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) copies—present in all cells—and the number of Foxp3
demethylated gene copies—present only in Tregs.
These pronounced dependencies, at least within blocks of loci with small genomic distance,
lead to conservativity of traditional multiple test procedures like the Bonferroni correction,
meaning that α is not exhausted. For the classes of multiple test procedures considered in this
work, non-exhaustion of α is equivalent to sub-optimal power characteristics of the multiple
tests; cf. Lemma 3.1 of [9].
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Furthermore, several confounding factors of DNA methylation have been identified in pre-
vious work, e. g., methylation is known to be highly correlated with age. A test for case-control
methylation data addressing this dependency was developed in [10] and extended in [11].
Several parametric models for the distribution of the β-values have been proposed, see [12].
Their parametric nature limits their applicability in practice. A nonparametric analysis of
methylation data was suggested in [13] and [14]. However, a formal notion of multiplicity ad-
justment is lacking in their work. In the present paper we develop a nonparametric statistical
framework for tight FWER control in the context of analyzing epigenetic methylation studies,
taking the described dependencies among loci into account, leading to multivariate procedures.
Methods
Throughout the remainder, we label reported results from the literature as propositions. Our
major own mathematical contribution is Theorem 1.
Basic Model
Suppose that we have two experimental groups denoted by A and B, for instance given by a dis-
ease status. We consider N 2 N observational units with nA observables in group A and nB in
group B, such that N = nA+nB. We assume that all N observables are stochastically independent
and that the observations in group i 2 {A,B} are realizations of independent and identically dis-
tributed (iid.) d-dimensional random vectorsXik ¼ ðXð1Þik ; . . . ;XðdÞik Þ>; where the index i 2 {A,
B} denotes the group and 1 k ni indexes the k-th observational unit within group i, while
the superscript denotes the coordinate. The random vectors are assumed to follow the distribu-
tion L(XA1) = P or L(XB1) = Q, respectively.
Example 1 (Identifying differentially methylated CpG loci) Consider an epigenetic methyl-
ation dataset comprising d CpG loci. For each locus ℓ a methylation ratio (occasionally referred
to as β-value) is defined as
Xð‘Þ ¼ M
ð‘Þ
Mð‘Þ þ U ð‘Þ ; ð1Þ
where M(ℓ) (U(ℓ)) is an intensity value for the amount of methylated (unmethylated) cells at locus
ℓ, where we assume that suitable preprocessing steps have been performed prior to the statistical
analysis. In previous literature the family of beta distributions has been considered as a model
for the distribution of X(ℓ), e. g., in [15]. However, often bimodality and skewness are encoun-
tered, questioning this parametric assumption. Notice also that numerator and denominator in
Eq (1) are highly dependent. As we are not aware of a model capturing the aforementioned distri-
butional characteristics, we propose a nonparametric approach as in [14]. An application of our
general methodology to a two-sample problem involving such data is presented in Section “Iden-
tiﬁcation of differentially methylated CpG loci”.
Example 2 (Group differences for immune relevant parameters) As a second example,
consider the comparison of human colorectal tissue for two different stages of cancer as well as
healthy controls. In Section “Association of immune cell counts with cancer” we analyze data
from a study in which three immune relevant parameters were measured utilizing novel epige-
netic markers based on methylation signatures in tissue. Since no prior information about distri-
butional properties of these marker data are at hand, our nonparametric approach is applied,
only making use of our basic model assumptions. Three two-group comparisons are made re-
garding differences of the immune relevant parameters between the disease stages.
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Aim of the statistical analysis
We denote by Fi the cumulative distribution function (cdf) of Xi1 with marginal cdfs F
ð‘Þ
i for
each coordinate 1 ℓ d. We are interested in testing two families of marginal hypotheses,
sayH = (Hℓ:1 ℓ d) andH0 ¼ ðH 0‘ : 1  ‘  dÞ. The familyH corresponds to marginal ho-
mogeneity in the sense of [16]. This means, one is interested in testing which of the coordi-
nate-specific marginal distributions are the same in both groups A and B, i. e.,
H‘ : F
ð‘Þ
A ¼ Fð‘ÞB versus K‘ : Fð‘ÞA 6¼ Fð‘ÞB :
The familyH0 corresponds to finding a particular type of coordinate-specific differences.
Namely, one is interested in detecting coordinates in which there are group differences in the
central tendencies of the marginal distributions. To this end, recall the definition of the relative
effect in the sense of [17].
Definition 1 (Relative effect) Let XA and XB denote two stochastically independent random
variables which are defined on a common probability space with probability measure P. Assume
that XA and XB have non-degenerate distributions and denote the normalized version of their
cdf, as considered in [18], by FA and FB, respectively. Then, the relative effect of FA with respect to
FB is defined as
pAB ¼ PðXA < XBÞ þ
1
2
PðXA ¼ XBÞ ¼
Z
FAdFB:
For a d-variate distribution the relative effects can be deﬁned coordinate-wise for each 1 ℓ d
by
pð‘ÞAB ¼
Z
Fð‘ÞA dF
ð‘Þ
B :
Let pAB ¼ ðpð1ÞAB; . . . ; pðdÞABÞ> denote the vector of marginal relative effects in the latter case.
The functional pAB is capturing central tendencies, i. e., whether realizations of one of the
distributions are tending to larger values than the ones from the other. Hence, we letH 0‘ :
pð‘ÞAB ¼ 1=2 with two-sided alternatives K 0‘ : pð‘ÞAB 6¼ 1=2, 1 ℓ d.
Let S {1,. . .,d}. In the remainder, we make use of the notation
HS ¼
\
‘2S
H‘; H0 ¼ Hf1;;dg ¼
\d
‘¼1
H‘;
and refer toH0 as the global hypothesis inH. An analogous notation applies for intersection
hypotheses inH0.
Test statistics and multiple test procedures
For the univariate nonparametric two-sample problem, i. e., for testing one particular hypothe-
sisHℓ, Wilcoxon’s rank sum test (or, equivalently, the Mann-Whitney U test) is commonly ap-
plied. We make use of multivariate generalizations described in [19] (for testingH), and in
[20] (for testingH0).
Wilcoxon-Mann-Whitney (WMW) statistic.
Definition 2 (Mann-Whitney U-Statistic) For 1 ℓ d, we let
U ð‘Þ ¼ 1
nAnB
XnA
j¼1
XnB
k¼1
fð‘ÞðXAj;XBkÞ
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with
fð‘ÞðXAj;XBkÞ ¼ IfXð‘ÞAj > Xð‘ÞBkg:
Proposition 1 (cf. Theorem 2 (iii) of [19]) Assume that ni/N! τi 2 (0,1) for N!1, i 2
{A,B}. Then, under H0, it holds that
UN ¼
ﬃﬃﬃﬃ
N
p
U ð1Þ  1
2
;    ;U ðdÞ  1
2
 
!D N dð0;SÞ; N !1; ð2Þ
where S = (σℓr)1  ℓ,r  d with entries
s‘r ¼
zð‘;rÞ10
tA
þ z
ð‘;rÞ
01
tB
;
zð‘;rÞ10 ¼ zð‘;rÞ01 ¼ Covðfð‘ÞðXAj;XBkÞ;fðrÞðXAj;XBk0 ÞÞ;
where 1 j nA and 1 k 6¼ k0  nB. In Eq (2) and throughout,!D denotes convergence in dis-
tribution, andNd(μ,S) stands for the d-variate normal distribution with mean μ and covariance
matrix S.
Corollary 1 (Theorem 9.1 in [19]) Let S^ be a consistent estimator of S. Assuming that det
(S)> 0 it holds that
WUN ¼ N UN 
1
2
1d
 >P^1 UN  121d
 
is under H0 asymptotically χ
2-distributed with d degrees of freedom as N!1.
Empirical relative effects. The empirical counterpart of the vector pAB of relative effects is
denoted by p^AB ¼ ðp^ð1ÞAB; . . . ; p^ðdÞABÞ> with p^ð‘ÞAB ¼
R
F^ ð‘ÞA dF^
ð‘Þ
B , 1 ℓ d, where F^ ð‘Þi , given by
F^ ð‘Þi ðxÞ ¼ n1i
Pni
k¼1
1
2
Ið1;xðXð‘Þik Þ þ Ið1;xÞðXð‘Þik Þ
 
, denotes the normalized version of the em-
pirical cdf in group i 2 {A,B} pertaining to coordinate ℓ. Notice that p^ð‘ÞAB ¼ 1 U ð‘Þ almost
surely for all 1 ℓ d, where U(ℓ) is as in Definition 2, under the assumption of absolutely
continuous distributions (that there is zero probability for ties).
Proposition 2 (Theorem 3.3 in [20]) Let VN 2 Rd×d denote the matrix with entries
vð‘;rÞN ¼
N
nA
cð‘;rÞA þ
N
nB
cð‘;rÞB ;
cð‘;rÞi ¼ CovðY ð‘Þi1 ;Y ðrÞi1 Þ; i 2 fA;Bg;
with the transformed random variables Y ð‘ÞAk ¼ Fð‘ÞB ðXð‘ÞAk Þ and Y ð‘ÞBk ¼ Fð‘ÞA ðXð‘ÞBk Þ. Assuming that
VN converges to a positive deﬁnite covariance matrix V as N!1, it holds that
TN ¼
ﬃﬃﬃﬃ
N
p ðp^AB  pABÞ!
D
N dð0;VÞ; N !1:
Furthermore, in (4.6) of [20] a consistent estimator V^ N defined via the ranks of the observa-
tions has been provided.
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Corollary 2Making use of Proposition 2 and a Studentization by V^ N , it follows by Slutsky’s
lemma in analogy to Corollary 1 that, under H 00 : pAB ¼ 1d=2, the statistic
WN ¼ N p^AB 
1
2
1d
 >
V^1N p^AB 
1
2
1d
 
is asymptotically w2d-distributed as N!1.
Closure principle. A (non-randomized) multiple testing procedure φ = (φ1,. . .,φd)
> for
testingH orH0, respectively, is a vector of measurable mappings (individual tests) from the
sample space into {0,1}d. In this, the event {ϕℓ = 1} means rejection of the ℓ-th null hypothesis
Hℓ orH 0‘, respectively. For given distributions P and Q, the FWER of φ is defined as the proba-
bility under (P,Q) of at least one type I error, i. e.,
FWERðP;QÞðφÞ ¼ PðP;QÞ
[
‘2I0ðP;QÞ
fφ‘ ¼ 1g
 !
;
where I0(P,Q) {1,. . .,d} denotes the index set of true null hypotheses inH orH0, respectively.
The multiple test φ is said to control the FWER strongly at a given level α 2 (0,1), if FWER(P,
Q)(φ) α for all possible pairs (P,Q).
One construction principle for FWER-controlling multiple tests is the closed test principle
according to [21]. The general idea behind this method is to add to the system of hypotheses of
interest all their intersectionsHS orH 0S, respectively, where S 2 2{1,. . .,d}. Even if these intersec-
tion hypotheses are not of scientific interest, they are tested auxiliarly in order to provide a
multiplicity correction. Namely, a closed test procedure tests every such intersection hypothesis
at full level α by an arbitrarily chosen level α test φS or φ0S, respectively. The adjustment for mul-
tiplicity is then performed via the decision rule that only those coordinate-specific hypotheses
Hℓ orH 0‘, respectively, are rejected for which all intersection hypothesesHS (H
0
S) with ℓ 2 S
have been rejected by φS (φ0S). Thus, the price to pay for the multiplicity of the problem is that
one has to perform 2d tests. A concise description of this principle can for instance be found in
Section 3.3 of [9].
Remark 1 Application of the closed test principle is particularly convenient in our context by
noticing that the assertions of Propositions 1 and 2 and their corollaries remain valid if the re-
spective full d-dimensional vector of test statistics is replaced by a subvector which only contains
the indices in the subset S to which φS or φ0S, respectively, refer. In the corollaries, only the degrees
of freedom of the asymptotic χ2-distributions have to be changed from d to jSj.
Resampling-based approach. The results from the previous sections can also be used to
construct asymptotically pivotal statistics for usage in a resampling approach. This strategy is
assumed to keep αmore accurately for finite N than the asymptotic methods resulting from
Corollaries 1 and 2. In [22], multivariate multiple permutation tests have been developed for
more restrictive families of hypotheses thanH orH0, namely, for families where differences of
coordinate-specific functionals of P and Q, respectively, are of interest. In contrast, the relative
effect depends both on P and on Q. In Theorem 1 we adapt the theory derived in [22] to the
case that multivariate relative effects are of interest. Thereby, we obtain an asymptotically
FWER-controlling resampling procedure based on the statisticWN orWUN , respectively.
To this end, let π denote an arbitrary but fixed permutation of the set {1,. . .,N} and letXp ¼
ðXpA1; . . . ;XpAnA ;X
p
B1; . . . ;X
p
BnB
Þ be the matrix containing the permuted observation vectors
from X = (XA1,. . .,XAnA, XB1,. . .,XBnB). We make the convention that the first nA columns of X
and Xπ correspond to group A and the remaining nB columns to group B. Denote by τ = τ(π,
nA,nB) the fraction of observations from group B within the first nA columns of X
π, and let
Simultaneous Statistical Inference for Epigenetic Data
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ppAB ¼ pA0B0 , where
LðXA01Þ ¼ tQþ ð1 tÞP ¼ P0 and
LðXB01Þ ¼ ðnA=nBÞtP þ ð1 ðnA=nBÞtÞQ ¼ Q0:
Analogously, let p^pAB ¼ p^A0B0 ðXpÞ denote the estimator of the vector of relative effects based on
the permuted data set Xπ. A simple calculation yields that
ppAB ¼ tð1þ nA=nBÞ1d=2þ ½ð1 tð1þ nA=nBÞpAB. Finally, let
ppAB ¼ tð1þ nA=nBÞ1d=2þ ½ð1 tð1þ nA=nBÞp^AB.
Theorem 1 Under the general setup from above, assume that the sample sizes nA and nB fulfill
the regularity assumptions given in Lemma 5.3 of [23] as N!1. Define the statistic
WpN ¼ Nðp^pAB  ppABÞ>ðV^ pNÞ1ðp^pAB  ppABÞ; ð3Þ
where V^ p^N denotes the estimator from (4.6) in [20] applied to X
π. Then, the permutation distribu-
tion of WpN (i. e., its discrete distribution induced by letting π be uniformly distributed on all N!
possible permutations of the set {1,. . .,N}, while keeping the data X ﬁxed), the cdf of which we de-
note by R^W^N , satisﬁes
8t 2 ½0;1Þ : jR^WN ðtÞ  Fw2dðtÞj!P 0; N !1:
A result analogous to Theorem 1 can be obtained for the statisticWUN . Based on them, an as-
ymptotic null distribution forWN orWUN , respectively, is given by its permutation distribution.
This permutation distribution, in connection with Remark 1, can be used instead of w2jSj in
order to calibrate each test ϕS or 
0
S, respectively, for type I error control at level α.
Proof of Theorem 1. We approximate the conditional distribution (given X) of Xπ by an
asymptotically equivalent unconditional two-groups model. To this end, denote by Z = (Z1,. . .,
ZN) a random matrix, the columns of which are stochastically independent such that the first
nA columns are distributed as P0 and the remaining nB columns are distributed as Q0. Following
the argument of Theorem 3.5 in [20] the statistic TN(Z) has asymptotically a centered d-variate
normal distribution with some covariance matrix which is non-degenerate for eventually all
large N under our general assumptions. Also, we note that both p^pAB and p
p
AB consistently esti-
mate ppAB. Applying the reasoning of Lemma 5.3 in [23], together with the continuous mapping
theorem and Slutsky’s lemma, completes the proof.
Remark 2 In dimension d = 1, a similar Studentized permutation approach has been dis-
cussed in [24]; see also [25].
Results
Computer simulations
In this section we consider the performance of the proposed tests in terms of type I error con-
trol and power. To this end we present results of computer simulations under the
following model.
Model 1 For each coordinate ℓ 2 {1,. . .,d} the marginal cdf Fð‘Þi , i 2 {A,B}, is the cdf of the
beta distribution with shape parameters equal to að‘Þi and b
ð‘Þ
i . In all simulations, the value of the
second shape parameter bð‘Þi was fixed as b
ð‘Þ
i ¼ 4 for all 1 ℓ d and i 2 {A,B}. We consider d
2 {2,5,10} and set the values of the first shape parameter equal to að‘Þi ¼ 3 in both groups for co-
ordinates 1,. . .,d0, where d0 denotes the number of true null hypotheses. For the remaining d1 = d
−d0 coordinates the values of the first shape parameter in group A are taken as a
ð‘Þ
A ¼ 3, while in
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group B the corresponding values are given as að‘ÞB ¼ 3þ d, where δ takes values in
{0.5,1,1.5,2,2.5,3}.
The dependency between the marginals is modeled by the correlation matrix R of a Gaussian
copula CS, where S is the covariance matrix originating from R and the marginal variances in-
duced by the shape parameters. The correlation matrix R = (Rℓ,r) is of AR(1) structure, i. e., Rℓ,r
= ρjℓ−rj, 1 ℓ,r d, where ρ takes values in {0,0.2,0.4,0.6,0.8}. This model is motivated by inter-
preting coordinates as epigenetic loci and considering a decreasing strength of dependency with
increasing epigenetic distance.
First, we assessed the accuracy of the χ2 approximation (Proposition 2 in connection with
Corollary 2) and the permutation-based approximation (Theorem 1) of the null distribution of
WN, respectively, under the global null hypothesis. The empirical type I error rate was calculat-
ed as the relative frequency of occurrences of type I errors when testing the global null hypothe-
sis (d1 = 0), i. e.,
1
K
XK
k¼1
IfφðkÞðxðkÞÞ ¼ 1g;
where φ(k) denotes the test of the global hypothesis H0 in the k-th of K simulation runs and x
(k)
the pseudo-sample in simulation run k. The empirical power of the test of the global null hy-
pothesis was calculated as the same frequency for the cases with d1> 0.
Second, type I error control of the multiple tests employing the closure principle was as-
sessed by the FWER. Empirical values of the FWER were calculated as the relative frequency of
the occurrence of at least one type I error, i. e.,
dFWER ¼ 1
K
XK
k¼1
If91  j  d0 : φjðkÞðxðkÞÞ ¼ 1g;
where φ(k) = (φ1(k),. . .,φd(k))
> stands for the multiple test in the k-th simulation run.
For the sample size N, we considered two different regimes, namely moderate (nA = 20, nB =
30) and large (nA = 100, nB = 150). Tables 1 and 2 display empirical type I error rates for testing
the global hypothesis in the moderate and large sample regimes, respectively. The empirical
power for testing the global hypothesis is presented in Tables 3 and 4. Finally, Table 5 displays
empirical values of the FWER, both in the moderate and in the large sample regime. The nomi-
nal significance or FWER level, respectively, was set to 5% in all simulations. The permutation
test was carried out as a Monte Carlo permutation test employing 9,999 randomly chosen per-
mutations of {1,. . .,N}, together with the identity permutation.
In both sample size regimes, the empirical type I error rate of the permutation test is below
the desired level of 0.05, indicating its applicability even for moderate sample sizes. In contrast,
the test depending on critical values from the limiting χ2 distribution performs liberally in all
simulation settings displayed in Tables 1 and 2. With increasing dimension this test even be-
comes more and more liberal. For example, its empirical type I error rate rises up to 20% for
d = 10. On the other hand the stronger the dependency between the coordinates, the less liberal
the χ2-based test.
Of course, the more stringent type I error control of the permutation test, compared with
the asymptotic χ2-based test, leads to lower power, see Tables 3 and 4. However, the differences
in power become smaller for increasing δ.
Regarding the empirical FWER (Table 5), we again observe that the permutation test keeps
the level better than the χ2-based multiple test, where level exceedances of the latter occur for
large δ and small ρ> 0 in the moderate sample size regime.
Simultaneous Statistical Inference for Epigenetic Data
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Table 1. Type I error for the global hypothesis, moderate sample sizes.
d = 2 d = 5 d = 10
ρ χ 2 Perm χ 2 Perm χ 2 Perm
0 0.0654 0.0428 0.1034 0.0432 0.2154 0.0480
0.2 0.0668 0.0432 0.1092 0.0478 0.2064 0.0408
0.4 0.0730 0.0488 0.1092 0.0482 0.2092 0.0476
0.6 0.0654 0.0426 0.1012 0.0494 0.1898 0.0468
0.8 0.0628 0.0460 0.0848 0.0410 0.1662 0.0448
Monte Carlo simulation results, based on K = 10,000 repetitions, regarding the type I error rate for testing the global hypothesis in the moderate sample
size regime (nA = 20,nB = 30) for the asymptotic χ
2-based test (χ2) and the permutation test (Perm). The data have been generated according to Model 1
with correlation parameter ρ. The nominal signiﬁcance level was set to α = 5% in all simulations. The permutation test was carried out as a Monte Carlo
permutation test employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t001
Table 2. Type I error for the global hypothesis, large sample sizes.
d = 2 d = 5 d = 10
ρ χ 2 Perm χ 2 Perm χ 2 Perm
0 0.0527 0.0464 0.0604 0.0448 0.0734 0.0460
0.2 0.0551 0.0456 0.0554 0.0396 0.0772 0.0500
0.4 0.0543 0.0453 0.0590 0.0440 0.0792 0.0476
0.6 0.0520 0.0440 0.0526 0.0396 0.0708 0.0458
0.8 0.0547 0.0486 0.0585 0.0460 0.0640 0.0468
Monte Carlo simulation results, based on K = 10,000 repetitions, regarding the type I error rate for testing the global hypothesis in the large sample size
regime (nA = 100,nB = 150) for the asymptotic χ
2-based test (χ2) and the permutation test (Perm). The data have been generated according to Model 1
with correlation parameter ρ. The nominal signiﬁcance level was set to α = 5% in all simulations. The permutation test was carried out as a Monte Carlo
permutation test employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t002
Table 3. Power for rejecting the global hypothesis, moderate sample sizes.
δ 0.5 1 1.5 2 2.5 3
d1 = 1 χ
2 0.1456 0.2696 0.4540 0.6512 0.7948 0.8984
Perm 0.0682 0.1524 0.2948 0.4964 0.6674 0.8176
d1 = 2 χ
2 0.1702 0.3384 0.5834 0.7986 0.9152 0.9700
Perm 0.0890 0.2016 0.4148 0.6556 0.8270 0.9314
d1 = 3 χ
2 0.1976 0.4108 0.6882 0.8780 0.9700 0.9926
Perm 0.1008 0.2722 0.5354 0.7824 0.9178 0.9736
d1 = 4 χ
2 0.2082 0.4744 0.7768 0.9296 0.9882 0.9982
Perm 0.1098 0.3170 0.6402 0.8592 0.9642 0.9932
d1 = 5 χ
2 0.2236 0.5182 0.8168 0.9580 0.9946 0.9992
Perm 0.1188 0.3560 0.6894 0.9056 0.9806 0.9962
Monte Carlo simulation results, based on K = 10,000 repetitions, regarding the power for testing the global hypothesis in the moderate sample size regime
(nA = 20,nB = 30) for the asymptotic χ
2-based test (χ2) and the permutation test (Perm). The data have been generated according to Model 1 with
correlation parameter ρ and d = 5. The nominal signiﬁcance level was set to α = 5% in all simulations. The permutation test was carried out as a Monte
Carlo permutation test employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t003
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Empirical illustration
In this section, we present applications of the proposed methods to two epigenetic studies. We
applied the multiple tests based on the statistics defined in Section “Test statistics and multiple
test procedures” in combination with the closure principle and Remark 1.
On one hand, we re-analyzed a representative study utilizing a whole genome approach,
which aimed at the discovery of novel epigenetic markers to distinguish healthy (or good prog-
nosis) donors from those with disease (or bad prognosis). The primary statistical challenge of
such studies is the high number of locus-specific tests based on a sample with a moderate num-
ber of observations. On the other hand, we re-analyzed a data set regarding three immune
Table 4. Power for rejecting the global hypothesis, large sample sizes.
δ 0.5 1 1.5 2 2.5 3
d1 = 1 χ
2 0.2574 0.7732 0.9850 0.9998 1 1
Perm 0.2228 0.7326 0.9804 0.9996 1 1
d1 = 2 χ
2 0.3624 0.9136 0.9990 1 1 1
Perm 0.3202 0.8938 0.9974 1 1 1
d1 = 3 χ
2 0.4494 0.9676 1 1 1 1
Perm 0.4020 0.9524 0.9998 1 1 1
d1 = 4 χ
2 0.5250 0.9848 1 1 1 1
Perm 0.4760 0.9804 1 1 1 1
d1 = 5 χ
2 0.5760 0.9924 1 1 1 1
Perm 0.5258 0.9900 1 1 1 1
Monte Carlo simulation results, based on K = 10,000 repetitions, regarding the power for testing the global hypothesis in the large sample size regime (nA
= 100,nB = 150) for the asymptotic χ
2-based test (χ2) and the permutation test (Perm). The data have been generated according to Model 1 with
correlation parameter ρ and d = 5. The nominal signiﬁcance level was set to α = 5% in all simulations. The permutation test was carried out as a Monte
Carlo permutation test employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t004
Table 5. Empirical family-wise error rates.
d1 0 1 2 3 4
nA = 20,ρ = 0.1 χ
2 0.050 0.056 0.060 0.061 0.065
nB = 30,δ = 3 Perm 0.021 0.024 0.032 0.036 0.049
nA = 20,ρ = 0.5 χ
2 0.046 0.045 0.045 0.035 0.026
nB = 30,δ = 1 Perm 0.021 0.016 0.018 0.017 0.011
nA = 100,ρ = 0.5 χ
2 0.028 0.030 0.033 0.029 0.024
nB = 150,δ = 0.5 Perm 0.020 0.020 0.024 0.022 0.018
Monte Carlo simulation results, based on K = 5,000 repetitions, regarding the FWER for the asymptotic χ2-based multiple test (χ2) and the multiple
permutation test (Perm). The data have been generated according to Model 1 with correlation parameter ρ and d = 5. The nominal FWER level was set to
α = 5% in all simulations. The permutation test was carried out as a Monte Carlo permutation test employing 9,999 randomly chosen permutations of
{1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t005
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relevant parameters which were derived from cell type specific real-time PCR markers in previ-
ous work (see, e. g., [3]).
Identification of differentially methylated CpG loci. The UK Ovarian Cancer Population
Study (see [26]) aimed at detecting differentially methylated loci between ovarian cancer cases
and healthy controls (GEO accession number GSE19711). To this end, 274 healthy controls
were compared with 131 untreated, confirmed ovarian cancer cases. Upon rigid quality control,
264 controls and 124 cases remained in the study. When applying our method, we randomly
assigned 176 and 84 controls and cases, respectively, to the screening sub-sample of a two-
stage selection approach (cf. [27] and references therein). We applied the univariate two-sam-
ple Wilcoxon test at each locus on the screening sample and ranked the resulting p-values in as-
cending order. The remaining 88 and 40 control and case subjects, respectively, were used for
the confirmatory analysis (second step). The ten top-ranked loci from the screening stage were
tested for a relative effect unequal 1/2 based on asymptotic critical values from the limit distri-
bution (χ2) and permutation-based critical values (Perm) on the confirmatory group. In
Table 6, the results are presented as multiplicity-adjusted p-values. For locus 1 ℓ 10, the
multiplicity-adjusted p-value denotes the smallest FWER level such thatH 0‘ is rejected by the
respective multiple test procedure. With both methods, all ten candidate CpG sites have a mul-
tiplicity-adjusted p-value below 5%, an FWER level which is often chosen in practice.
Among the ten loci displayed in Table 6, there are two which are associated with the FUT7
gene. In turn, the FUT7 gene encodes the Alpha-(1,3)-fucosyltransferase, see [28]. This enzyme
plays a role in connection with the surfaces of granulocytes, monocytes and natural killer cells.
Association of immune cell counts with cancer. As mentioned in Section “Basic Model”
the discussed rank-based methods can be applied under almost no assumptions due to their
nonparametric nature. Furthermore, our approach implicitly adapts to the dependency struc-
ture in the data via the permutation approach. Hence, it is especially well-suited for situations
with highly dependent coordinates, for example resulting from the consideration of
derived parameters.
Such a situation was present in [29]. In their study, a set of three pre-identified gene regions
was considered. These regions have been shown to be associated with particular cell types.
Namely, demethylated Foxp3 is associated with regulatory T-cells (Tregs), CD3 with all T-
cells, and GAPDH with all leukocytes. From this, three immune relevant parameters were de-
rived: the number of Tregs, the total number of T-cells (tTL) and the cellular ratio of immune
tolerance (immunoCRIT). As the Tregs constitute a subclass of the tTL and the immunoCRIT
Table 6. Results for the first real data example.
Locus cg00645579 cg00974864 cg02679745 cg08044694 cg09134726
χ 2 0.0046 0.0002 0.0002 0.0002 0.0002
Perm 0.0126 0.0029 0.0029 0.0029 0.0029
Locus cg09303642 cg09305224 cg20070090 cg24427660 cg24777950
χ 2 0.0002 0.0047 0.0001 0.0002 0.0002
Perm 0.0029 0.0146 0.0029 0.0076 0.0029
Multiplicity-adjusted p-values of the tests for relative effects for the loci selected at the screening stage based on the asymptotic χ2 multiple test (χ2) and
the multiple permutation test (Perm) in combination with the closure principle. The multiplicity-adjusted p-value for locus ℓ denotes the smallest
signiﬁcance level such that H0‘ is rejected for the actually observed data. The permutation test was carried out as a Monte Carlo permutation test
employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation.
doi:10.1371/journal.pone.0125587.t006
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is the ratio of the two other values, these three parameters are highly dependent. Nonetheless
each parameter is immune relevant in its own right.
We assessed the association of the three parameters with a disease indicator for cancer, with
cancerogenesis, and with cancer progression. In this context, the evaluation of the individual
roles of the parameters had to be investigated. This is because cancer tolerance may be either
driven by the immunoCRIT or by its individual components, i. e., the shear amount of Tregs or
all T-cells. In addition, it is important to understand, even if the most important part is the
immunoCRIT, which of the components drives the change during cancerogenesis. The results
are presented in Table 7.
Our data indicate a statistically significant role of all three parameters with respect to all
three endpoints, with the exception that the Treg parameter is not significantly associated with
cancer progression. Thus, our multiple permutation test confirms the notion that manifesta-
tion of cancer is strongly associated with a shift in immune tolerance as monitored by Tregs,
overall T-cells and the immunoCRIT. Notably, the change of the overall immunological toler-
ance from healthy towards cancer tissue is driven by both the number of Tregs and the overall
number of T-cells. However, once a tumor is established the continuing increase of immuno-
CRIT-mediated tolerance along with higher tumor stages is mainly caused by a diminished
overall T-cell number and not by Treg increase. Hence, while there is an undoubted dependen-
cy among these parameters, the biological mechanisms of cancer development allow for a de-
tachment of these parameters such that individual changes of one of the parameters can be
observed and statistically evaluated.
Discussion
Epigenetic data pose their individual set of issues for their statistical interpretation, since in
contrast to DNA and protein studies, they exhibit both linkage disequilibrium-type dependen-
cies and cell type specificity issues. Hence, dependencies have to be taken into account that go
Table 7. Results for the second real data example.
Parameter Treg tTL immunoCRIT
Cancer indicator:
Healthy colon versus colorectal cancer χ 2 < 10−16 4.926×10−13 < 10−16
Perm 0.0001 0.0001 0.0001
Cancerogenesis:
Healthy colon versus early stage cancer χ 2 5.292×10−12 0.0024 < 10−16
Perm 0.0001 0.0044 0.0001
Cancer progression:
Early stage cancer versus late stage cancer χ 2 0.9043 9.710×10−5 0.0002
Perm 0.9044 0.0005 0.0011
Multiplicity-adjusted p-values of the tests for relative effects with respect to disease groups for three different immune-relevant parameters based on the
asymptotic χ2 multiple test (χ2) and the multiple permutation test (Perm) in combination with the closure principle. The multiplicity-adjusted p-value for
parameter ℓ denotes the smallest signiﬁcance level such that H0‘ is rejected for the actually observed data. The permutation test was carried out as a
Monte Carlo permutation test employing 9,999 randomly chosen permutations of {1,. . .,N}, together with the identity permutation. Treg: number of
regulatory T-cells, tTL: total number of T-cells, immunoCRIT: cellular ratio of immune tolerance
doi:10.1371/journal.pone.0125587.t007
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beyond the linear and parametric linkage of genetic loci, and the cell-specific linkage of
expression patterns.
Here, we assessed a new method to cope with these statistical issues in a general manner.
We demonstrated how group differences in epigenetic data can reliably be detected. To this
end, a statistical approach based on hypotheses regarding central tendencies in combination
with nonparametric Studentized multivariate multiple permutation tests has been proposed.
We adapted the theory of [22] such that it can be applied to the analysis of relative effects. In
particular, our methodology addresses the so-called “null dilemma” in the sense of [16], be-
cause Studentization leads to asymptotically pivotal test statistics, even if the dependency struc-
ture differs between the groups. Our approach features four important characteristics for
analyzing epigenetic methylation data: (i) The use of the relative effect as a functional for the
definition of differential methylation allows to declare a shift in central tendencies in case of a
significant finding. This is particularly important as other studies, see [2], have found that vari-
ation in DNA methylation may play an important role in the development of complex diseases
like cancer. The restriction to shift alternatives, however, is convenient for the development of
certain epigenetic markers; (ii) the permutation-based approach keeps the desired type I error
level even for moderate sample sizes; (iii) carrying out the permutation test as a multivariate
procedure implicitly adapts to the dependency structure in the data; (iv) as we mentioned in
Section “Basic Model” the discussed rank-based methods can be applied under almost no as-
sumptions on the distribution of the data.
Computer simulations revealed that the permutation-based approach keeps the type I error
level more accurately than asymptotic χ2 approximations of the distribution of Wald-type sta-
tistics, especially in cases with moderate sample sizes. The latter finding is in line with the ob-
servations from [30]. The convergence of Wald-type statistics towards their limiting χ2
distribution is known to be slow and this problem becomes more severe for
increasing dimensionality.
As indicated in the real data examples above, epigenetic studies usually involve several loci
simultaneously based on a single sample. In many medical applications, the number of obser-
vations is very limited. Each of the given examples represents one extreme—but very common
—experimental set-up: Microarray analyses with thousands of mildly dependent CpGs as in
Example 1 bear a substantial risk of false positives, even when relatively high sample sizes are
at hand. On the other end an unknown or complicated dependency structure in the data poses
a statistical challenge. This issue is true for both directly adjacent CpGs, which are usually
comethylated as well as when technically independent markers functionally overlap. The latter
case was considered in Example 2 with the Foxp3 gene as marker for Tregs, and CD3g/d inter-
genic region as marker for the overall T-cells.
As usual for resampling procedures, our approach based on permutations in combination
with the closure principle is computationally much more demanding than asymptotic approxi-
mations based on tabulated χ2-quantiles. However, computations can be parallelized with re-
spect to the subsets S in the closed test procedure such that the computing time can be
distributed among nodes in a cluster computing system. Furthermore, efficient shortcut ver-
sions (step-down variants) of the closed test procedure can be employed; see [31] for details.
Possible extensions of our methodology comprise multi-sample problems with more than
two groups, as well as the consideration of other types of limit laws (e. g., coming from extreme
value theory). Finally, Edgeworth expansions as in [32] for the Wald-type statistic can prevent
the costly resampling steps, at least if some concrete distributional assumptions for the obser-
vational units can be justified.
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Supporting Information
S1 Table. Data for the second real data example. The table contains measurements of three
immune-relevant parameters for patients in different stages of colon cancer.
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